# Premenstrual Dysphoric Disorder and Antiepileptic Drugs

> **NCT00612235** · — · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 80 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Lamotrigine
- **DRUG:** Levetiracetam
- **DRUG:** Carbamazepine
- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT00612235
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2018-10-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00612235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00612235, "Premenstrual Dysphoric Disorder and Antiepileptic Drugs". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00612235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*